Status
Conditions
About
The project's objective is to carry out prospectively, in France, for one year, a descriptive registry study in the management of patients with borderline or locally advanced pancreatic adenocarcinoma, and to collect both the patient's demographic characteristics, but also the therapeutic regimens applied, the types of surgeries performed and the outcome of the patients after surgery, and at three months of follow up (preoperative data, complications's post surgery, quality of the resection, etc.)
Full description
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Any patient over the age of 18, operated on for pancreatic adenocarcinoma, borderline or locally advanced, between September 2022 and August 2023, in France
Diagnosis of pancreatic adenocarcinoma:
Borderline or locally advanced character depending on the presence of a contact of the tumor with nearby vessels and defined by morphological examination (scanner +/- MRI). These criteria are defined by the NCCN Guidelines for Pancreatic Adenocarcinoma V.1.2021, international reference
Exclusion criteria
Loading...
Central trial contact
Lise Laclautre
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal